• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Seres Therapeutics, Inc. - Common Stock (NQ:MCRB)

6.110 -0.630 (-9.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 154,450
Open 6.730
Bid (Size) 6.030 (500)
Ask (Size) 6.700 (100)
Prev. Close 6.740
Today's Range 6.025 - 6.848
52wk Range 5.310 - 29.98
Shares Outstanding 127,901,391
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Seres Therapeutics’ SER-155 Posts 80% Response in Cancer Immunotherapy GI Toxicity Study ↗
Today 14:02 EDT
Seres Therapeutics (NASDAQ:MCRB) reported results from an investigator-sponsored study of SER-155 in immune checkpoint inhibitor-related enterocolitis, or irEC, saying the data support further... 
Via MarketBeat
News headline image
MCRB Stock Declines As Seres Therapeutics Pauses SER-155 Phase 2 Study And Shrinks Headcount By 30% ↗
February 12, 2026
The company said that it will continue to seek funding for the SER-155 Phase 2 study. 
Via Stocktwits

Performance

YTD
-59.7%
-59.7%
1 Month
-5.9%
-5.9%
3 Month
-26.6%
-26.6%
6 Month
-61.0%
-61.0%
1 Year
-50.5%
-50.5%

More News

Read More
News headline image
The Great Biotech Re-Shoring: Seres Therapeutics and the New Commodity-Driven Era
December 19, 2025
Via MarketMinute
Topics Earnings Economy Intellectual Property
News headline image
Earnings Scheduled For November 5, 2025 ↗
November 05, 2025
Via Benzinga
News headline image
Earnings Scheduled For August 6, 2025 ↗
August 06, 2025
Via Benzinga
News headline image
Earnings Scheduled For May 7, 2025 ↗
May 07, 2025
Via Benzinga
News headline image
Which stocks are gapping on Friday? ↗
November 21, 2025
Via Chartmill
News headline image
Keep an eye on the top gainers and losers in Thursday's session. ↗
November 20, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
November 20, 2025
Via Benzinga
News headline image
Seres (MCRB) Q3 2025 Earnings Call Transcript ↗
November 05, 2025
Via The Motley Fool
Topics Earnings
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
November 03, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
September 08, 2025
Via Benzinga
News headline image
Top movers in Monday's pre-market session ↗
September 08, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
September 08, 2025
Via Benzinga
News headline image
Why Robinhood Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket ↗
September 08, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
August 08, 2025
Via Benzinga
News headline image
Seres (MCRB) Q2 Loss Narrows 34% ↗
August 06, 2025
Via The Motley Fool
News headline image
Seres Therapeutics Inc (NASDAQ:MCRB) Reports Q2 2025 Earnings: Narrower EPS Loss but Shares Dip in Pre-Market ↗
August 06, 2025
Via Chartmill
News headline image
Uncovering Potential: Seres Therapeutics's Earnings Preview ↗
August 05, 2025
Via Benzinga
News headline image
This Coty Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday ↗
May 08, 2025
Via Benzinga
News headline image
Uber To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday ↗
May 08, 2025
Via Benzinga
News headline image
Quest Diagnostics Posts Better-Than-Expected Earnings, Joins Pentair, 3M, Danaher And Other Big Stocks Moving Higher On Tuesday ↗
April 22, 2025
Via Benzinga
News headline image
Stay updated with the stocks that are on the move in today's pre-market session. ↗
April 15, 2025
Via Chartmill
News headline image
Stay updated with the stocks that are on the move in today's after-hours session. ↗
April 14, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
April 14, 2025
Via Benzinga

Frequently Asked Questions

Is Seres Therapeutics, Inc. - Common Stock publicly traded?
Yes, Seres Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Seres Therapeutics, Inc. - Common Stock trade on?
Seres Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Seres Therapeutics, Inc. - Common Stock?
The ticker symbol for Seres Therapeutics, Inc. - Common Stock is MCRB on the Nasdaq Stock Market
What is the current price of Seres Therapeutics, Inc. - Common Stock?
The current price of Seres Therapeutics, Inc. - Common Stock is 6.110
When was Seres Therapeutics, Inc. - Common Stock last traded?
The last trade of Seres Therapeutics, Inc. - Common Stock was at 07/10/26 04:00 PM ET
What is the market capitalization of Seres Therapeutics, Inc. - Common Stock?
The market capitalization of Seres Therapeutics, Inc. - Common Stock is 781.48M
How many shares of Seres Therapeutics, Inc. - Common Stock are outstanding?
Seres Therapeutics, Inc. - Common Stock has 781M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap